Creative Medical Technology Holdings, Inc. (CELZ) Earnings History
Net Loss20 years of earnings data (2006–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Creative Medical Technology Holdings, Inc. (CELZ) Earnings Overview
As of June 22, 2026, Creative Medical Technology Holdings, Inc. (CELZ) reported trailing twelve-month net income of -$6M, reflecting +32.1% year-over-year growth. The company earned $-1.56 per diluted share over the past four quarters, with a net profit margin of -99916.8%.
Looking at the long-term picture, CELZ's historical earnings data spans multiple years. The company achieved its highest annual net income of $19M in fiscal 2021.
Creative Medical Technology Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MESO (-$102M net income, -593.9% margin), NKTR (-$158M net income, -297.1% margin), RCEL (-$45M net income, -67.8% margin), CELZ has room to improve margins relative to the peer group. Compare CELZ vs MESO →
CELZ Earnings vs Peers
Earnings metrics vs comparable public companies
CELZ Historical Earnings Data (2006–2025)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$6M | -9.1% | -$6M | $-2.52 | -99916.8% | -102380.2% |
| 2024 | -$5M | -3.9% | -$6M | $-3.71 | -49940.7% | -52216.9% |
| 2023 | -$5M | +47.9% | -$6M | $-3.76 | -58739.7% | -62445.9% |
| 2022 | -$10M | -152.8% | -$10M | $-9.28 | -11449.3% | -11562.5% |
| 2021 | $19M | +152.9% | -$3M | $56.10 | 21892.8% | -3562.2% |
| 2020 | -$36M | -328.2% | -$1M | $-626.88 | -22082.2% | -677.7% |
| 2019 | -$8M | +37.9% | -$1M | $-5017.67 | -5126.1% | -682.9% |
| 2018 | -$14M | -413.5% | -$1M | $-11351.33 | -10977.2% | -895.7% |
| 2017 | -$3M | -247.1% | -$1M | $-17379.79 | -55398.1% | -24537.6% |
| 2016 | $-766,072 | -2390.4% | $-766,072 | $-5471.94 | - | - |
| 2015 | $-30,761 | -9.8% | $-20,831 | $-1281.71 | - | - |
| 2014 | $-28,012 | -2.7% | $-19,426 | $-1167.17 | - | - |
| 2013 | $-27,282 | -6.6% | $-20,120 | $-1136.75 | - | - |
| 2012 | $-25,585 | -6.4% | $-20,096 | $-1066.04 | - | - |
| 2011 | $-24,055 | -39.4% | $-19,830 | $-1002.29 | - | - |
| 2010 | $-17,256 | +45.4% | $-14,290 | $-719.00 | - | - |
| 2009 | $-31,610 | +39.9% | $-30,553 | $-1317.08 | - | - |
| 2008 | $-52,636 | -451.5% | $-53,490 | $-2193.17 | - | - |
| 2007 | $-9,544 | -795.6% | $-13,617 | $-397.67 | - | - |
| 2006 | $1,372 | - | $-1,431 | $57.17 | - | - |
Download Data
Export CELZ earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
20+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CELZ — Frequently Asked Questions
Quick answers to the most common questions about buying CELZ stock.
What is CELZ earnings per share (EPS)?
CELZ trailing twelve-month (TTM) diluted EPS is $-1.56, reflecting +32.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2006 to 2025 is available in the table on this page.
What is Creative Medical Technology Holdings, Inc.'s net income?
Creative Medical Technology Holdings, Inc. (CELZ) trailing twelve-month net income is $-6M as of 2025. Earnings grew +32.1% year-over-year.
Is CELZ profitable?
CELZ is not currently profitable on a TTM basis, reporting a net loss of $-6M. Net margin is -99916.8%. Investors should monitor for a return to profitability.
What is CELZ's earnings growth rate?
CELZ compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2006 to 2025.
What are CELZ's profit margins?
Creative Medical Technology Holdings, Inc. net profit margin is -99916.8%, operating margin is -102380.2%, and gross margin is +63.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is -86.5%.
Is CELZ growing earnings?
Yes, CELZ earnings are accelerating — EPS growth of +32.1% exceeds the 5-year CAGR of N/A. TTM net income reached $-6M. Earnings momentum is strengthening.
What was CELZ's best earnings year?
Creative Medical Technology Holdings, Inc.'s highest annual net income on record is $19M, achieved in fiscal year 2021. Earnings history on this page spans 2006 to 2025 and includes all annual and quarterly figures.
What were CELZ's earnings last quarter?
CELZ's most recent reported quarter was Q1 2026. Net income was $-1M with diluted EPS of $-0.38. For a full breakdown of all quarters, see the quarterly earnings table on this page.